Serum tumour markers in the era of development of molecular biology techniques in oncology
Authors:
M. Šimičková 1; M. Nekulová 1; L. Pecen 3; T. Frgala 2; D. Valík 1
Authors‘ workplace:
Masarykův onkologický ústav, Brno
Ředitel: Prof. MUDr. Rostislav Vyzula, CSc.
Oddělení laboratorní medicíny
Primář: MUDr. Dalibor Valík Ph. D.
1; Masarykův onkologický ústav, Brno
Ředitel: Prof. MUDr. Rostislav Vyzula, CSc.
Oddělení gynekologie
Primář: MUDr. Miloš Bláha
2; Ústav informatiky AV ČR, Praha
Vedoucí: doc. Ing. E. Pelikán, CSc.
3
Published in:
Prakt. Lék. 2007; 87(5): 294-298
Category:
Diagnostis
Overview
This article summarizes the current understanding about classical serum tumour markers and the possibility of their use in oncological practice at a time of intensive development in molecular biology techniques. These new procedures, based at the molecular level, have yet to replace serum tumour markers in clinical practice. The importance of serum markers mainly lies in monitoring disease recurrence and following the effectiveness of therapy, as outlined (and regularly updated) in international scientific publications. Fully automatic determinations of serum tumour markers are non-invasive, economically efficient procedures, which enable the dynamics of their changes during malignant disease to be monitored and thus contribute to the rationalization of oncological therapy.
Key words:
serum tumour markers, guidelines, follow-up of disease progression, prediction of therapy effectiveness.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2007 Issue 5
-
All articles in this issue
- Acute renal failure
- Skin and alcohol
- Health promotion for ageing employees in the workplace
- Occupational Health and company practice
- Somatisation in childhood and adolescence
- The impact an educational film has on secondary school pupils’ knowledge of cardiopulmonary resuscitation
- Nurses and delirious states in hospitalized patients
- Serum tumour markers in the era of development of molecular biology techniques in oncology
- Diabetes mellitus as one of the risk factors for colorectal carcinoma. Role of PPAR receptors
- Differential diagnostic of leucopenias
- General Practitioner
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Differential diagnostic of leucopenias
- Skin and alcohol
- Somatisation in childhood and adolescence
- Acute renal failure